GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » Volatility

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Volatility : 31.25% (As of May. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-05-28), Zhejiang Cheng Yi Pharmaceutical Co's Volatility is 31.25%.


Competitive Comparison of Zhejiang Cheng Yi Pharmaceutical Co's Volatility

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Cheng Yi Pharmaceutical Co's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Cheng Yi Pharmaceutical Co's Volatility Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co's Volatility distribution charts can be found below:

* The bar in red indicates where Zhejiang Cheng Yi Pharmaceutical Co's Volatility falls into.



Zhejiang Cheng Yi Pharmaceutical Co  (SHSE:603811) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Cheng Yi Pharmaceutical Co  (SHSE:603811) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Zhejiang Cheng Yi Pharmaceutical Co Volatility Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Chemical Road, Dongtou District, Zhejiang Province, Wenzhou, CHN, 325700
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
Executives
Ke Ze Hui Director
Ren Bing Jun Director
Yan Yi Yi Director
Ceng Huan Qun Director
Li Shi Sheng Director
Qiu Ke Rong Director
Lv Sun Zhan senior management
Zhang Gao Qiao Supervisors
Zhang Zhi Hong senior management
Mao Li Ping senior management
Zhuang Xiao Ping Director
Lin Xin Chen senior management
Shen Ai Lan Director
Zhang Fu Fu Supervisors

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Headlines

No Headlines